Early volume variation of positive lymph nodes assessed by in-room mega voltage CT images predicts risk of loco-regional relapses in head and neck cancer patients treated with intensity-modulated radiotherapy

Acta Oncologica

Volumn 54, Issue 9, 2015, Pages 1490-1495

  Belli, Maria Luisa ^a   Fiorino, Claudio ^a   Zerbetto, Flavia ^a   Raso, Roberta ^a   Broggi, Sara ^a   Chiara, Anna ^a   Cattaneo, Giovanni Mauro ^a   Di Muzio, Nadia ^a   Delloca, Italo ^a   Calandrino, Riccardo ^a  

^a SAN RAFFAELE HOSPITAL   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; CANCER RADIOTHERAPY; CANCER RECURRENCE; CANCER SIZE; CANCER SURVIVAL; COMPARATIVE STUDY; COMPUTER ASSISTED EMISSION TOMOGRAPHY; COMPUTER ASSISTED TOMOGRAPHY; CONTROLLED STUDY; FEMALE; FOLLOW UP; HEAD AND NECK CANCER; HUMAN; INTENSITY MODULATED RADIATION THERAPY; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MALE; MEGAVOLTAGE COMPUTED TOMOGRAPHY; PET-CT SCANNER; PRIORITY JOURNAL; RADIATION DOSE FRACTIONATION; RADIATION RESPONSE; RECEIVER OPERATING CHARACTERISTIC; RECURRENCE FREE SURVIVAL; RETROSPECTIVE STUDY; TOMOTHERAPY; TREATMENT OUTCOME; HEAD AND NECK NEOPLASMS; IMAGE GUIDED RADIOTHERAPY; LYMPH NODE; MIDDLE AGED; PATHOLOGY; RADIOGRAPHY; SPIRAL COMPUTER ASSISTED TOMOGRAPHY; TUMOR RECURRENCE; VERY ELDERLY;

ADULT; AGED; AGED, 80 AND OVER; DOSE FRACTIONATION; FEMALE; FOLLOW-UP STUDIES; HEAD AND NECK NEOPLASMS; HUMANS; LYMPH NODES; MALE; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; RADIOTHERAPY, IMAGE-GUIDED; RADIOTHERAPY, INTENSITY-MODULATED; RETROSPECTIVE STUDIES; TOMOGRAPHY, SPIRAL COMPUTED;

EID: 84955464125     PISSN: 0284186X     EISSN: 1651226X     Source Type: Journal    
DOI: 10.3109/0284186X.2015.1062137     Document Type: Article

References (24)

1. Broggi S, Perna L, Bonsignore F, Rinaldin G, Fiorino C, Chiara A, et al. Static and rotational intensity modulated techniques for head-neck cancer radiotherapy: A planning comparison. Phys Med 2014; 30: 973-9.
2. Daly ME, Lieskovsky Y, Pawlicki T, Yau J, Pinto H, Kaplan M, et al. Evaluation of patterns of failure and subjective salivary function in patients treated with intensity modulated radiotherapy for head and neck squamous cell carcinoma. Head Neck 2007; 29: 211-20.
3. Aziz NM. Cancer survivorship research: State of knowledge, challenges and Opportunities. Acta Oncol 2007; 46: 417-32.
4. Hoeben BAW, Starmans MHW, Leijenaar RTH, Dubois LJ, van der Kogel A, Kaanders JH, et al. Systematic analysis of 18F-FDG PET and metabolism, proliferation and hypoxia markers for classification of head and neck tumors. BMC Cancer 2014; 14: 130.
5. Picchio M, Kirienko M, Mapelli P, DellOca I, Villa E, Gallivanone F, et al. Predictive value of pre-therapy 18F-FDG PET/CT for the outcome of 18F-FDG PET-guided radiotherapy in patients with head and neck cancer. Eur J Nucl Med Mol Imaging 2014; 41: 21-31.
6. Due AK, Vogelius IR, Aznar MC, Bentzen SM, Berthelsen AK, Korreman SS, et al. Recurrences after intensity modulated radiotherapy for head and neck squamous cell carcinoma more likely to originate from regions with high baseline [18F]-FDG uptake. Radiother Oncol 2014; 111: 360-5.
7. Fiorino C, DellOca I, Pierelli A, Borggi S, De Martin E, Di Muzio N, et al. Significant improvement in normal tissue sparing and target coverage for head and neck cancer by means of helical tomotherapy. Radiother Oncol 2006; 78: 276-82.
8. Barker JL, Garden AS, Ang KK, ODaniel JC, Wang H, Court LE, et al. Quantification of volumetric and geometric changes occurring during fractionated radiotherapy for head-and-neck cancer using an integrated CT/linear accelerator system. Int J Radiat Oncol Biol Phys 2004; 59: 960-70.
9. Belli ML, Zerbetto F, Raso R, Chiara A, Cattaneo GM, Di Muzio N, et al. Characterization of volume and shape modifications of PET-positive nodes during Tomotherapy for head and neck cancer as assessed by MVCTs. Radiother Oncol 2015; 115: 50-5.
10. Salma KJ, Sinae K, Syed AH, Xiaoting X, Alson W, Sujani S, et al. Reduction in tumor volume by cone beam computed tomography predicts overall survival in non-small cell lung cancer treated with chemoradiation therapy. Int J Radiat Oncol Biol Phys 2015; 92: 627-33.
11. Baumann M, Hölscher T, Zips D. The future of IGRT-cost benefit analysis. Acta Oncol 2008; 47: 1188-92.
12. Grau C, Olsen DR, Overgaard J, Høyer M, Lindegaard JC, Muren LP. Biology-guided adaptive radiation therapy-presence or future? Acta Oncol 2010; 49: 884-7.
13. Grau C, Høyer M, Alber M, Overgaard J, Lindegaard JC, Muren LP. Biology-guided adaptive radiotherapy (BiGART)-more than a vision? Acta Oncol 2013; 52: 1243-7.
14. Rødal J, Rusten E, Søvik Å, Skogmo HK, Malinen E. Functional imaging to monitor vascular and metabolic response in canine head and neck tumors during fractionated radiotherapy. Acta Oncol 2013; 52: 1293-9.
15. Hoeben BAW, Bussink J, Troost EGC, Oyen WJG, Kaanders JHAM. Molecular PET imaging for biology-guided adaptive radiotherapy of head and neck cancer. Acta Oncol 2013; 52: 1257-71.
16. Huang SH, OSullivan B, Xu W, Zhao H, Chen D-D, Ringash J, et al. Temporal nodal regression and regional control after primary radiation therapy for N2-N3 head-and-neck cancer stratified by HPV status. Int J Radiat Oncol Biol Phys 2013; 87: 1078-85.
17. Edge SB, Compton CC. The American Joint Committee on Cancer: The 7th edition of the AJCC cancer staging manual and the future of TNM. Ann Surg Oncol 2010; 17: 1471-4.
18. Sobin LH, Gospodarowicz MK, Wittekind CH, editors. TNM classification of malignant tumors, 7th ed. Oxford: Wiley-Blackwell; 2009.
19. Mourad WF, Hu KS, Harrison LB. Cranial nerves IX-XII contouring atlas for head and neck cancer: Cranial nerves atlas. RTOG (Radiation Therapy Oncology Group), available at link: http://www.rtog.org/CoreLab/ContouringAtlases/HNAtlases.aspx
20. Lee JA. Segmentation of positron emission tomography images: Some recommendations for target delineation in radiation oncology. Radiother Oncol 2010; 96: 302-7.
21. Fiorino C, DellOca I, Pierelli A, Brogli S, Cattaneo GM, Chiara A, et al. Simultaneous integrated boost (SIB) for nasopharynx cancer with Helical Tomotherapy. Strahlenther Onkol 2007; 183: 497-505.
22. van den Broek GB, Rasch CR, Pameijer FA, Peter E, van den Brekel MW, et al. Pretreatment probability model for predicting outcome after intraarterial chemoradiation for advanced head and neck carcinoma. Cancer 2004; 101: 1809-17.
23. Nathu RM, Mancuso AA, Zhu TC, Mendenhall WM. The impact of primary tumor volume on local control for oropharyngeal squamous cell carcinoma treated with radiotherapy. Head Neck 2000; 22: 1-5.
24. Begg AC. Predicting recurrence after radiotherapy in head and neck cancer. Semin Radiat Oncol 2012; 22 (2): 108-18.